The tumor was positive for both estrogen receptors (ER) (90%) and progesterone receptors (PR) (70%), negative for human epidermal growth factor receptor 2 (c-erbB-2), and positive for Ki-67 (15%). The gene discussed is ERBB2; the disease is neoplasm.